Ross Vlahos
Department of Pharmacology
The University of Melbourne
VIC 3010
Australia
Name/email consistency: high
- Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Vlahos, R., Bozinovski, S., Chan, S.P., Ivanov, S., Lindén, A., Hamilton, J.A., Anderson, G.P. Am. J. Respir. Crit. Care Med. (2010)
- Modelling COPD in mice. Vlahos, R., Bozinovski, S., Gualano, R.C., Ernst, M., Anderson, G.P. Pulm. Pharmacol. Ther (2006)
- Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Vlahos, R., Bozinovski, S., Jones, J.E., Powell, J., Gras, J., Lilja, A., Hansen, M.J., Gualano, R.C., Irving, L., Anderson, G.P. Am. J. Physiol. Lung Cell Mol. Physiol. (2006)
- Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Vlahos, R., Bozinovski, S., Hamilton, J.A., Anderson, G.P. Pharmacol. Ther. (2006)
- Cromakalim inhibits transmitter acetylcholine release in rat trachea by an action on epithelial cells and a diffusible factor. Vlahos, R., Fabiani, M.E., Story, D.F. Naunyn Schmiedebergs Arch. Pharmacol. (2003)